Drug development companies can use Cytocast Whole Cell Simulator to accelerate drug development. - Cytocast

Drug development companies can use Cytocast Whole Cell Simulator to accelerate drug development.

ADVstudio2021-02-25T19:24:24+00:00

Related Posts

Cytocast gains regulatory approval for informing treatment decisions in patients with Fibrosis
Cytocast can simulate drugs acting on surface protein receptors
Cytocast can simulate the transcriptional modification caused by drug administration.
Covid-19 didn’t stop us! We fight to stop COVID: we use Cytocast to find treatments against lung fibrosis, which causes some of the complications for patients.
A demo of Cytocast Whole Cell Simulator© is released
2020: Cytocast wins the ”Promising future for a Medical Professional ” award at the Health Ventures Lab of GE Healthcare
Cytocast is incorporated in Budapest
Cytocast correctly predict the effects of Metformin treatment
Cytocast proof of concept is published in Plos Computational Biology